Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US
Comparison of iLivTouch and FibroScan for the Assessment of Liver Fibrosis and Steatosis in Adult Patients in the US: A Multicenter, Cross-sectional, and Prospective Study
Sponsor: Baylor University
This observational or N/A phase trial investigates Fatty Liver and Liver Fibrosis and is currently ongoing. Baylor University leads this study, which shows 5 recorded versions since 2023 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Dec 2025 — Present [monthly]
Unknown
Status: Recruiting → Unknown
-
Sep 2024 — Dec 2025 [monthly]
Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Recruiting
-
Nov 2023 — Jul 2024 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Not Yet Recruiting
First recorded
Sep 2023
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Baylor University
- NYU Langone Health
- New Discovery LLC
- Rush University
- Stanford University
- Wuxi Hisky Medical Technology Co Ltd
For direct contact, visit the study record on ClinicalTrials.gov .